Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples